VI

Vivet Therapeutics

Paris, FR · 6 known investors

vivet-therapeutics.com ↗

Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.

Investors · 6

HE

HealthCapStockholm

KU

Kurma PartnersParis · $162K – $10.8M

NO

Novartis Venture FundBasel · $5M – $25M

RO

Roche Venture FundBasel · $648K – $3.2M

YS

Ysios CapitalBarcelona · $5.4M – $21.6M

CO

Columbus Venture PartnersreportedValenciavia Jose Mesa · inferred